Provision of Clinical Preventive Services by Community Pharmacists
SPECIAL TOPIC — Volume 13 — December 1, 2016
PEER REVIEWED
Of the 95 US Preventive Services Task Force recommendations, there were 43 excluded because the recommendation was rated C, D, or I; 10 were excluded as pediatric recommendations; and 10 were excluded as being for pregnancy or lactation. Of the 32 recommendations remaining and included in the study, 18 were opportunities for pharmacists to conduct screenings and provide recommendations and referrals (Table 1) and 14 were opportunities for pharmacists to provide education and referrals (Table 2). Examples related to folic acid supplementation, tobacco use, osteoporosis, and HIV were selected to demonstrate various services.
Figure. Determination of US Preventive Services Task Force recommendations to review with regard to provision of clinical preventive services by community pharmacists. The US Preventive Services Task Force states that recommendations with a C rating be offered or provided to selected patients based on individual circumstances, D-rated recommendations should be discouraged, and I-rated recommendations have insufficient evidence to assess the balance of benefits and harms for the service.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.